ClinicalTrials.gg
Active, not recruitingNCT07932756Updated Nov 12, 2026

Comparative Effects of Two Hands-On Ankle Treatments on Range of Motion, Dynamic Balance and Hop Performance in Amateur Footballers With Ankle Instability

An interventional study of Maitland Grade III Mobilization and Mulligan Mobilization with Movement (MWM) in Joint Instability and Ankle Injuries, sponsored by University of Management and Technology Lahore. Active, not recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment

Updated Nov 12, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn which of two hands-on ankle treatments works better for amateur footballers aged 18 to 35 with unstable ankles, meaning ankles that keep "giving way" after an old sprain. The study will find out which treatment better improves how far the ankle bends upward, balance while standing and reaching on one leg, and hopping on the injured leg compared with the healthy leg. Researchers will compare Maitland mobilization, where the therapist gently and rhythmically moves the ankle joint while the participant lies still, with Mulligan mobilization, where the therapist holds the ankle bones in a guided position while the participant bends the ankle. Participants will receive one of the two treatments, followed by ankle strengthening exercises, 3 times a week for 8 weeks. They will complete simple tests of ankle movement, balance and hopping at the start, at week 4 and at week 8.

02

Conditions studied

  • Joint Instability
  • Ankle Injuries

Keywords

  • Ankle Injuries
  • Joint Instability
  • Musculoskeletal Manipulations
  • Postural Balance
  • Range of Motion, Articular
  • soccer
  • athletes
03

In context

Joint Instability

117 studies on the registry are indexed under Joint Instability; 22 are open to participants now.

This study's enrollment of 44 is close to the median of 45 across 59 interventional studies indexed under Joint Instability.

Browse Joint Instability studies →

Lead sponsor

University of Management and Technology Lahore is the lead sponsor of 42 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Amateur footballers aged 18 to 35 years, of either gender
  • Chronic ankle instability as per International Ankle Consortium criteria: at least -episodes of ankle giving way in the past 6 months and perceived instability persisting for at least 12 months after an initial lateral ankle sprain
  • Cumberland Ankle Instability Tool (CAIT) score of 24 or less
  • At least 2 years of organized amateur football experience
  • Willing to give written and comply with the 8-week intervention and follow-up schedule

Exclusion criteria

Exclusion Criteria:

  • History of ankle/foot fracture, dislocation or surgery on the affected limb
  • Acute lateral ankle sprain (Grade II to III) within the previous 3 months
  • Mechanical instability on anterior drawer or talar tilt test suggesting ligament rupture requiring surgical referral
  • Generalized joint hypermobility, systemic inflammatory/rheumatological disease, or neurological disorder affecting balance or proprioception
  • Other concurrent lower-limb musculoskeletal injury (knee, hip or contralateral ankle) affecting function
  • Pregnancy
  • Manual therapy, taping or bracing for the ankle within the previous 4 weeks
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
44 participants (actual)

Study arms

  • Active comparator
    Maitland Grade III Mobilization

    Maitland Grade III talocrural mobilization followed by a peroneal strengthening programme, 3 sessions per week for 8 weeks.

    Other: Maitland Grade III Mobilization

  • Experimental
    Mulligan Mobilization with Movement (MWM)

    Mulligan mobilization with movement followed by the same peroneal strengthening programme, 3 sessions per week for 8 weeks.

    Other: Mulligan Mobilization with Movement (MWM)

Interventions

  • OtherMaitland Grade III Mobilization

    Maitland Grade III talocrural joint mobilization applied by the treating physical therapist with the participant in supine and the ankle over the edge of the treatment couch. Large-amplitude oscillatory glides are performed up to the limit of available range to restore talar accessory glide and improve dorsiflexion. Dosage: 3 sets of 60 seconds per session with 30 to 60 seconds rest between sets.

  • OtherMulligan Mobilization with Movement (MWM)

    A sustained fibular / antero-posterior accessory glide is applied by the therapist while the participant actively performs pain-free dorsiflexion (e.g., weight-bearing lunge). Dosage: 10 repetitions per set, 3 sets, with adequate rest between sets.

06

What researchers measure

Primary outcomes

  1. Ankle Dorsiflexion Range of Motion: Weight-Bearing Lunge Test (WBLT)

    Measures ankle dorsiflexion ROM under functional, weight-bearing conditions. The participant lunges forward so the knee touches a wall while the heel stays on the ground; the maximum distance between the great toe and the wall (cm), or the tibial inclination angle measured with an inclinometer, is recorded. Greater values indicate more dorsiflexion.

    Time frame: Baseline, Week 4 (interim) and Week 8 (post-intervention)

  2. Star Excursion Balance Test (SEBT)

    A validated clinical measure of dynamic postural control and neuromuscular control. The participant stands barefoot on the test limb at the centre of a grid of eight lines at 45 degree increments and reaches as far as possible with the opposite limb in eight directions (anterior, anteromedial, medial, posteromedial, posterior, posterolateral, lateral, anterolateral). Three successful trials are performed per direction. Reach distances are normalized to limb length and expressed as a percentage of limb length; greater values indicate better dynamic balance.

    Time frame: Baseline, Week 4 (interim) and Week 8 (post-intervention)

  3. Single-Leg Hop Tests, Limb Symmetry Index (LSI)

    A battery of single-leg hop tests (single hop for distance, triple hop for distance, crossover hop for distance and timed 6-metre hop). Performance of the involved limb is expressed as a Limb Symmetry Index (%) relative to the uninvolved limb; higher LSI indicates more symmetrical hop performance.

    Time frame: Baseline, Week 4 (interim) and Week 8 (post-intervention)

07

Study locations

1 site
08

References and documents

Related links

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the published results will be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: 6 months after the publication of the manuscript.

Access criteria: The data can be requested from the corresponding author.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2026 (actual). Primary completion is estimated for Jan 2027, 2 months after the start.

Of 37 non-industry interventional studies with no phase under Joint Instability, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 37. This study's planned 2 months is below that.

Counting every sponsor, half of 42 studies reached it within 15 months; a quarter within 7 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2026
First posted
Nov 12, 2026
StartActual
Nov 5, 2026
Primary completionEst.
Jan 10, 2027
CompletionEst.
Jan 10, 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07932756
Lead sponsor
University of Management and Technology Lahore
Responsible party
Komal Ahmed (Lecturer, University of Management and Technology Lahore) — Principal investigator
First posted
Nov 12, 2026
Start date
Nov 5, 2026
Primary completion
Jan 10, 2027 (estimated)
Completion
Jan 10, 2027 (estimated)
Last update
Nov 12, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion